Gilead Sciences, Inc. 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-26 4:33 pm Purchase |
2020-10-16 | 13G | Jounce Therapeutics, Inc. JNCE |
GILEAD SCIENCES INC GILD |
5,539,727 13.900% |
5,539,727 (New Position) |
Filing |